Company Analysis DaVita
1. Summary
Advantages
- The stock's return over the last year (58.5%) is higher than the sector average (-2.16%).
- Current debt level 49.87% is below 100% and has decreased over 5 years from 64.59%.
- The company's current efficiency (ROE=65.48%) is higher than the sector average (ROE=-80.86%)
Disadvantages
- Price (153.4 $) is higher than fair price (91.77 $)
- Dividends (0%) are below the sector average (1.31%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
DaVita | Healthcare | Index | |
---|---|---|---|
7 days | 2.4% | 2.4% | 1.7% |
90 days | 8.5% | -6.3% | 4.6% |
1 year | 58.5% | -2.2% | 24.9% |
DVA vs Sector: DaVita has outperformed the "Healthcare" sector by 60.66% over the past year.
DVA vs Market: DaVita has outperformed the market by 33.62% over the past year.
Stable price: DVA is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: DVA with weekly volatility of 1.13% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (153.4 $) is higher than the fair price (91.77 $).
Price is higher than fair: The current price (153.4 $) is 40.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (14.06) is lower than that of the sector as a whole (57.88).
P/E vs Market: The company's P/E (14.06) is lower than that of the market as a whole (47.66).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.54) is lower than that of the sector as a whole (9.4).
P/BV vs Market: The company's P/BV (3.54) is lower than that of the market as a whole (22.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.8008) is lower than that of the sector as a whole (4.07).
P/S vs Market: The company's P/S indicator (0.8008) is lower than that of the market as a whole (15.21).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (8.68) is lower than that of the sector as a whole (17.62).
EV/Ebitda vs Market: The company's EV/Ebitda (8.68) is lower than that of the market as a whole (24.14).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -2.12% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-2.12%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-66.62%).
5.4. ROE
ROE vs Sector: The company's ROE (65.48%) is higher than that of the sector as a whole (-80.86%).
ROE vs Market: The company's ROE (65.48%) is higher than that of the market as a whole (18.07%).
5.5. ROA
ROA vs Sector: The company's ROA (3.92%) is lower than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (3.92%) is lower than that of the market as a whole (6.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (8.72%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (8.72%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.31%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (34.88%) are at a comfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
Transaction date | Insider | Type | Price | Volume | Quantity |
---|---|---|---|---|---|
27.11.2024 | Waters Kathleen Alyce Chief Legal & Pub. Affairs Off |
Purchase | 108.93 | 879 937 | 8 078 |
27.11.2024 | Michael Staffieri Officer |
Purchase | 167.09 | 1 320 340 | 7 902 |
13.08.2024 | Kathleen Waters Officer |
Purchase | 146.2 | 1 148 690 | 7 857 |
12.05.2023 | YALE PHYLLIS R Director |
Sale | 95.26 | 209 191 | 2 196 |
12.05.2023 | YALE PHYLLIS R Director |
Purchase | 66.29 | 474 968 | 7 165 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription